COVID-19, Flu, RSV Vaccine Coverage Low for Nursing Home Residents
By Elana Gotkine HealthDay Reporter
.jpg?width=1200)
TUESDAY, Nov. 26, 2024 -- COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents early in the 2024 to 2025 season, according to research published in the Nov. 21 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Noting that nursing homes are required to report COVID-19 vaccination coverage and can report influenza and RSV vaccination coverage, Hannah E. Reses, M.P.H., from the CDC in Atlanta, and colleagues examined COVID-19, influenza, and RSV vaccination coverage among nursing home residents early in the 2024 to 2025 COVID-19 season using data reported to the CDC National Healthcare Safety Network.
The researchers found that 29.7 percent of nursing home residents had received a 2024 to 2025 COVID-19 vaccine as of Nov. 10, 2024. Among residents at the 59.4 and 51.8 percent of facilities that elected to report vaccination against influenza and RSV, 58.4 and 17.9 percent had received influenza and RSV vaccination, respectively. There was variation seen in vaccination coverage by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size.
"Most nursing home residents have not been afforded the protection offered by vaccination against severe COVID-19, influenza, and RSV disease during the 2024-25 respiratory virus season," the authors write. "Addressing low coverage of vaccination against COVID-19, influenza, and RSV must be prioritized."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
Azelastine Nasal Spray Reduces Risk for SARS-CoV-2 Infection
FRIDAY, Sept. 5, 2025 -- Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study...
COVID-19 Tied to Higher Risk for Inflammatory Diseases of the Airways
THURSDAY, Aug. 28, 2025 -- People who have had COVID-19 have an increased risk for developing certain new-onset type 2 inflammatory diseases of the airways, while receipt of a...
29 Percent of Infants Immunized Against RSV in 2023 to 2024 Season
MONDAY, Aug. 25, 2025 -- Overall, 29 percent of infants born during October 2023 to March 2024 were immunized against respiratory syncytial virus (RSV) during the 2023 to 2024...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.